Drugmakers’ plan: Sell tomorrow to shore up yesterday
April 19, 2011 | Analyst Insight
A wave of announced and expected divestitures is sweeping the pharmaceutical industry. Most recently, Pfizer announced an agreement to sell its $1 billion (revenue) drug-delivery technology group Capsugel for $2.4...
About Lux Research
Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.